TransEnterix (TRXC) Shares Gap Up to $1.37

Shares of TransEnterix, Inc. (NYSEAMERICAN:TRXC) gapped up before the market opened on Wednesday . The stock had previously closed at $1.39, but opened at $1.37. TransEnterix shares last traded at $1.42, with a volume of 60502 shares.

A number of equities analysts have commented on TRXC shares. Zacks Investment Research cut shares of TransEnterix from a “hold” rating to a “sell” rating in a research note on Wednesday. BTIG Research raised shares of TransEnterix from a “neutral” rating to a “buy” rating and set a $3.00 price target for the company in a research note on Tuesday.

TransEnterix (NYSEAMERICAN:TRXC) last released its quarterly earnings results on Thursday, May 9th. The medical instruments supplier reported ($0.09) EPS for the quarter, hitting the Zacks’ consensus estimate of ($0.09). The company had revenue of $2.18 million during the quarter, compared to analysts’ expectations of $4.50 million.

In other news, CFO Joseph P. Slattery sold 88,871 shares of the company’s stock in a transaction on Friday, February 22nd. The shares were sold at an average price of $3.25, for a total value of $288,830.75. Following the completion of the sale, the chief financial officer now owns 44,929 shares of the company’s stock, valued at approximately $146,019.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

A number of large investors have recently bought and sold shares of TRXC. Hsbc Holdings PLC bought a new position in TransEnterix in the 1st quarter worth $29,000. Zurcher Kantonalbank Zurich Cantonalbank bought a new position in TransEnterix in the 4th quarter worth $29,000. Cetera Advisors LLC bought a new position in TransEnterix in the 4th quarter worth $34,000. Whitnell & Co. bought a new position in TransEnterix in the 1st quarter worth $35,000. Finally, Sheets Smith Wealth Management raised its holdings in TransEnterix by 100.0% in the 1st quarter. Sheets Smith Wealth Management now owns 20,000 shares of the medical instruments supplier’s stock worth $48,000 after purchasing an additional 10,000 shares in the last quarter.

TRADEMARK VIOLATION WARNING: This story was published by WKRB News and is owned by of WKRB News. If you are reading this story on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The correct version of this story can be accessed at https://www.wkrb13.com/2019/05/15/transenterix-trxc-shares-gap-up-to-1-37.html.

About TransEnterix (NYSEAMERICAN:TRXC)

TransEnterix, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe.

See Also: What is required to own or exchange cryptocurrency?

Receive News & Ratings for TransEnterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransEnterix and related companies with MarketBeat.com's FREE daily email newsletter.